Two Sigma Advisers’s Zai Lab ZLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-60,100
Closed -$2.1M 2679
2025
Q2
$2.1M Buy
60,100
+21,900
+57% +$720K ﹤0.01% 1094
2025
Q1
$1.38M Buy
38,200
+20,000
+110% +$615K ﹤0.01% 1311
2024
Q4
$477K Buy
18,200
+4,200
+30% +$117K ﹤0.01% 1793
2024
Q3
$338K Buy
+14,000
New +$265K ﹤0.01% 1864
2022
Q2
Sell
-41,300
Closed -$1.82M 2908
2022
Q1
$1.82M Sell
41,300
-78,000
-65% -$3.77M ﹤0.01% 1318
2021
Q4
$7.5M Buy
119,300
+104,300
+695% +$8.84M 0.02% 604
2021
Q3
$1.58M Buy
15,000
+13,400
+838% +$1.92M ﹤0.01% 1379
2021
Q2
$283K Sell
1,600
-10,500
-87% -$1.69M ﹤0.01% 2157
2021
Q1
$1.61M Buy
12,100
+4,900
+68% +$759K ﹤0.01% 1379
2020
Q4
$974K Buy
+7,200
New +$733K ﹤0.01% 1578
2020
Q3
Sell
-10,225
Closed -$840K 2660
2020
Q2
$840K Buy
+10,225
New +$692K ﹤0.01% 1664

Other funds holding ZLAB

Two Sigma Advisers's ZLAB Position: Q3 2025 in Review

Two Sigma Advisers sold out of Zai Lab (ZLAB) in Q3 2025, closing a stake of 60,100 shares — an estimated $2.1M sold.

Two Sigma Advisers first reported a position in ZLAB in Q2 2020 and held it in 11 quarters. The position peaked at $7.5M in Q4 2021. 138 funds tracked by Wall St. Rank hold ZLAB as of Q3 2025.

  • Two Sigma Advisers reported no remaining Zai Lab position as of Q3 2025 after selling out during the quarter.
  • Two Sigma Advisers sold 60,100 Zai Lab shares in Q3 2025, an estimated $2.1M.
  • Two Sigma Advisers first reported a position in Zai Lab in Q2 2020 and held it in 11 quarters.
  • Two Sigma Advisers's Zai Lab position peaked at $7.5M in Q4 2021.
  • 138 funds tracked by Wall St. Rank held Zai Lab as of Q3 2025.

Based on Two Sigma Advisers's 13F filing for Q3 2025, filed 14 Nov 2025.